Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bristol-Myers-Squibb
Company Monitoring Page for Bristol-Myers-Squibb
latest headlines for company on cafepharma
Karuna, Cerevel might be just the start of psychiatry drug M&A
BioPharma Dive
Tue, 01/23/24 - 11:17 am
Tags:
M&A
,
Karuna Therapeutics
,
Cerevel Therapeutics
,
schizophrenia
,
AbbVie
,
Bristol Myers Squibb
Two more pharmas practice their Accent, invest in $75M series C round
Fierce Biotech
Tue, 01/23/24 - 10:47 am
Tags:
Accent Therapeutics
,
funding
,
RNA
,
Bristol Myers Squibb
,
JNJ
,
AbbVie
Another big pharma competed for Karuna, submitting all-cash offer day before BMS deal announcement
Fierce Biotech
Mon, 01/22/24 - 10:17 pm
Tags:
Karuna Therapeutics
,
Bristol Myers Squibb
,
M&A
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset
Fierce Pharma
Sun, 01/21/24 - 05:09 pm
Tags:
Bristol Myers Squibb
,
colorectal cancer
,
Opdivo-Yervoy
Jilted by Bristol Myers, Ikena cuts headcount by 35% in retreat from drug discovery
Fierce Biotech
Fri, 01/19/24 - 09:28 am
Tags:
Ikena Oncology
,
Bristol Myers Squibb
,
layoffs
JPM24: Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals
Fierce Pharma
Tue, 01/9/24 - 10:49 am
Tags:
Bristol Myers Squibb
,
Pharma CEOs
,
Christopher Boerner
,
JPMHC 2024
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
Tags:
M&A
,
JPMHC 2024
,
AbbVie
,
AstraZeneca
,
Bristol Myers Squibb
,
Carmot Therapeutics
,
Eli Lilly
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
Tags:
M&A
,
AstraZeneca
,
Gracell Biotechnologies
,
Bristol Myers Squibb
,
Rayze Bio
,
Roche
BMS enters radiopharma race with $4.1B acquisition of RayzeBio just 3 months after biotech went public
Fierce Biotech
Wed, 12/27/23 - 11:15 pm
Tags:
Bristol Myers Squibb
,
RayzeBio
,
radiopharmaceuticals
,
M&A
Bristol Myers to acquire brain drug developer Karuna for $14B
BioPharma Dive
Fri, 12/22/23 - 09:44 am
Tags:
Bristol Myers Squibb
,
Karuna Therapeutics
,
schizophrenia
,
M&A
,
KarXT
Bristol Myers pays SystImmune $800M and adds to pharma’s ‘ADC’ deal spree
BioPharma Dive
Tue, 12/12/23 - 09:58 am
Tags:
Bristol Myers Squibb
,
SystImmune
,
antibody-drug conjugate
,
cancer
ASH: Abecma’s survival data show why FDA wanted expert meeting on the Bristol Myers cell therapy
Fierce Pharma
Mon, 12/11/23 - 10:55 pm
Tags:
ASH 2023
,
Abecma
,
FDA
,
CAR-T
,
Bristol Myers Squibb
Bristol Myers Squibb bids farewell to dealmaking czar Elizabeth Mily
Fierce Pharma
Sun, 12/10/23 - 11:03 pm
Tags:
Bristol Myers Squibb
,
M&A
,
Elizabeth Mily
BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer
BioSpace
Fri, 12/8/23 - 10:00 am
Tags:
Bristol Myers Squibb
,
Opdivo
,
Yervoy
,
colorectal cancer
,
metastatic colorectal cancer
,
clinical trials
BMS chases Merck/Seagen with first-line bladder cancer filing
Pharmaphorum
Tue, 12/5/23 - 11:53 pm
Tags:
Bristol Myers Squibb
,
Opdivo
,
bladder cancer
,
urothelial cancer
,
Merck
,
Seagen
BMS, Avidity add another link to cardiovascular partnership with $100M expansion
Fierce Biotech
Tue, 11/28/23 - 10:29 am
Tags:
Bristol Myers Squibb
,
Avidity Biosciences
,
R&D
,
cardiovascular disease
FDA to delay decision on Bristol Myers-2seventy bio cancer therapy
Reuters
Mon, 11/20/23 - 10:12 am
Tags:
Bristol Myers Squibb
,
2seventy bio
,
blood cancer
,
FDA
,
Abecma
BMS gets US approval for ROS1 lung cancer drug Augtyro
Pharmaphorum
Thu, 11/16/23 - 10:11 am
Tags:
Bristol Myers Squibb
,
Augtyro
,
Turning Point Therapeutics
,
lung cancer
,
FDA
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Motley Fool
Sun, 11/12/23 - 09:30 pm
Tags:
Merck
,
Bristol Myers Squibb
,
antibody-drug conjugate
Bristol Myers pays $100M for a different kind of ADC
BioPharma Dive
Mon, 11/6/23 - 09:54 am
Tags:
Bristol Myers Squibb
,
antibody-drug conjugate
,
bone cancer
,
blood cancer
,
Orum Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.